About Us

Our team is committed to enhancing our understanding of human disease.

Technology

Transforming the measurement of disease progression in vivo using noninvasive biosensors.

Pipeline

Bioengineered, tunable sensors that are designed for each protease-mediated disease.

Partners

Evolving the way diseases are understood, tracked and treated to accelerate the development of drugs.

News & Events

Transforming the way diseases are detected, tracked, treated, and understood.

Careers

Leveraging the profound advances in engineering, medicine, biotechnology, and machine learning.

Contact Us

We are proud to be members of the pre-eminent Cambridge biotech community.

TECHNOLOGY

Transforming the measurement of disease progression in vivo using noninvasive biosensors.

Explore

Pipeline

Bioengineered, tunable sensors that are designed for each protease-mediated disease.

Explore

Partners

Evolving the way diseases are understood, tracked and treated to accelerate the development of drugs.

Explore

At Glympse, we are focused on better understanding diseases to transform disease detection and predict treatment response.

Learn about our team

Disruptive Business Model

We blend the best of the drug-device development and regulatory pathway, the therapeutics go-to-market model, and a biology-rich data engine.

Learn about our investors
https://glympsebio.com/wp-content/uploads/2020/07/Scientists-Image.png

Technology
Benefits

New Frontier of Liquid Biopsies

Our protease activity-based biosensors are accurate, sensitive, specific and measured in a novel noninvasive approach.

Disease Monitoring

We have engineered tunable and specific biosensors to better understand important, complex diseases such as cancer, fibrosis, inflammation, and infections.

Drug Response Monitoring

By partnering with drug developers, physicians and payers, we can accelerate therapeutic development by rapidly determining patient response to treatment.

Data Engine

With predictive algorithms and machine learning, our technology has a unique approach to capture the biology inside the body and create a map for disease progression.

Explore our technology

SANGEETA BHATIA

Ted Talk

Glympse cofounder Dr. Sangeeta Bhatia discusses her work transforming the early detection of diseases, like cancer, by leveraging the miniaturization revolution to create ultra-sensitive, bioengineered sensors.